These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 6406466)

  • 1. Animal models used in prediction of antidepressant effects in man.
    Cooper BR; Howard JL; Soroko FE
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):63-6. PubMed ID: 6406466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacologic basis for therapeutic interest in bupropion.
    Soroko FE; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):67-73. PubMed ID: 6406467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of bupropion's mechanism of antidepressant activity.
    Ferris RM; Cooper BR; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM; Maxwell RA; Cooper BR; Soroko FE
    Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central effects of repeated treatment with bupropion.
    Klimek V; Nowak G; Czyrak A
    Pol J Pharmacol Pharm; 1985; 37(3):243-52. PubMed ID: 3934652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
    Cooper BR; Hester TJ; Maxwell RA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):127-34. PubMed ID: 6778989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predicted pharmacology of an antidepressant].
    Pinder RM
    Encephale; 1981; 7(4 Suppl):371-80. PubMed ID: 7318755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
    Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
    Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant profile of bupropion and three metabolites in mice.
    Martin P; Massol J; Colin JN; Lacomblez L; Puech AJ
    Pharmacopsychiatry; 1990 Jul; 23(4):187-94. PubMed ID: 2116631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 12. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review.
    Gardier AM; Guiard BP; Guilloux JP; Repérant C; Coudoré F; David DJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):23-42. PubMed ID: 19267769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
    Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
    Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion hydrochloride.
    Dufresne RL; Weber SS; Becker RE
    Drug Intell Clin Pharm; 1984 Dec; 18(12):957-64. PubMed ID: 6439541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavioral laboratory models and various tests in the evaluation of the effect of antidepressive drugs].
    Kostowski W
    Psychiatr Pol; 1987; 21(3):170-9. PubMed ID: 3321115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological profile of a new non tricyclic antidepressant: oxaflozane (1,766 Cerm)].
    Hache J; Duchene-Marullaz P; Streichenberger G
    Therapie; 1974; 29(1):81-93. PubMed ID: 4849381
    [No Abstract]   [Full Text] [Related]  

  • 17. [The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen].
    Mashkovskii MD; Polezhaeva AI; Avrutskii GIa; Vertozgadova OP; Smulevich AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(8):1234-8. PubMed ID: 5392529
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
    Itoh T; Tokumura M; Abe K
    Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of nomifensine: a review of animal studies.
    Fielding S; Szewczak MR
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):12-20. PubMed ID: 6370970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of antidepressants: successes and failures.
    Kelwala S; Stanley M; Gershon S
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):40-8. PubMed ID: 6222036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.